What is HC Wainwright’s Estimate for Calumet Q2 Earnings?

Calumet, Inc. (NASDAQ:CLMT) – Equities researchers at HC Wainwright decreased their Q2 2026 EPS estimates for Calumet in a research report issued to clients and investors on Monday, May 11th. HC Wainwright analyst A. Dayal now anticipates that the oil and gas company will post earnings per share of ($0.62) for the quarter, down from their prior estimate of ($0.59). HC Wainwright currently has a “Buy” rating and a $60.00 target price on the stock. The consensus estimate for Calumet’s current full-year earnings is ($0.18) per share. HC Wainwright also issued estimates for Calumet’s Q3 2026 earnings at ($0.29) EPS, Q4 2026 earnings at ($0.33) EPS, FY2026 earnings at ($1.89) EPS and FY2027 earnings at $0.69 EPS.

Calumet (NASDAQ:CLMT) last released its quarterly earnings data on Friday, May 8th. The oil and gas company reported ($3.64) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($3.31). The firm had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1 billion. During the same period in the prior year, the business earned ($1.87) EPS. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year.

A number of other equities research analysts also recently weighed in on CLMT. Weiss Ratings raised shares of Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday. The Goldman Sachs Group downgraded shares of Calumet from a “buy” rating to a “neutral” rating and set a $36.00 target price on the stock. in a research note on Friday, April 24th. TD Cowen raised their target price on shares of Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, March 5th. Finally, UBS Group reissued a “neutral” rating and set a $26.00 price target on shares of Calumet in a research note on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $33.60.

Calumet Trading Down 0.6%

CLMT stock opened at $32.12 on Wednesday. The firm has a 50 day moving average of $31.62 and a 200-day moving average of $24.99. Calumet has a 12 month low of $12.70 and a 12 month high of $36.94. The firm has a market capitalization of $2.79 billion, a P/E ratio of -14.87 and a beta of 0.72.

Insider Activity at Calumet

In related news, Director Daniel J. Sajkowski sold 3,310 shares of Calumet stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $34.46, for a total value of $114,062.60. Following the transaction, the director directly owned 81,958 shares of the company’s stock, valued at $2,824,272.68. The trade was a 3.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 4.07% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in CLMT. Mariner LLC increased its stake in shares of Calumet by 959.6% in the third quarter. Mariner LLC now owns 369,408 shares of the oil and gas company’s stock worth $6,742,000 after buying an additional 334,544 shares during the period. Marshall Wace LLP increased its stake in shares of Calumet by 35.8% in the third quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock worth $16,268,000 after buying an additional 234,766 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Calumet by 128.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 348,115 shares of the oil and gas company’s stock worth $6,917,000 after buying an additional 195,627 shares during the period. BNP Paribas Financial Markets increased its stake in shares of Calumet by 18,512.3% in the second quarter. BNP Paribas Financial Markets now owns 183,890 shares of the oil and gas company’s stock worth $2,897,000 after buying an additional 182,902 shares during the period. Finally, UBS Group AG boosted its holdings in Calumet by 90.0% in the fourth quarter. UBS Group AG now owns 358,628 shares of the oil and gas company’s stock valued at $7,126,000 after acquiring an additional 169,900 shares in the last quarter. 34.41% of the stock is owned by hedge funds and other institutional investors.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.